+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Primary Prevention of Cardiovascular Disease in Diabetes Mellitus



Primary Prevention of Cardiovascular Disease in Diabetes Mellitus



Journal of the American College of Cardiology 70(7): 883-893



Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D meet recommended guidelines for CVD prevention. The burden of T2D is increasing: by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with T2D will comprise an increasingly large proportion of the CVD population. The authors believe it is imperative that we expand the use of therapies proven to reduce CVD risk in patients with T2D. The authors summarize evidence and guidelines for lifestyle (exercise, nutrition, and weight management) and CVD risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and the use of aspirin) management for the prevention of CVD among patients with T2D. The authors believe appropriate lifestyle and CVD risk factor management has the potential to significantly reduce the burden of CVD among patients with T2D.

(PDF emailed within 0-6 h: $19.90)

Accession: 060133128

Download citation: RISBibTeXText

PMID: 28797359

DOI: 10.1016/j.jacc.2017.07.001


Related references

Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. Diabetes and Metabolism Journal 38(1): 32-34, 2014

Primary and secondary prevention strategy for cardiovascular disease in diabetes mellitus. Cardiology Clinics 29(1): 47-70, 2011

Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus. Diabetes, Obesity and Metabolism 11(11): 997-1000, 2011

Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?. Canadian Medical Association Journal 171(8): 857-857, 2004

Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy 64(15): 1603-1610, 2007

Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opinion on PharmacoTherapy 11(9): 1459-1466, 2010

Statins Ineffective for Primary Prevention of Cardiovascular Disease in Patients 75 Years or Older Without Diabetes Mellitus. American Family Physician 99(7): 461, 2019

Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?. Medicina Clinica 142(8): 358-359, 2014

Individual-based primary prevention of cardiovascular disease in Cambodia and Mongolia: early identification and management of hypertension and diabetes mellitus. Bmc Public Health 12: 254, 2012

Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials. Thrombosis and Haemostasis 104(6): 1085-1088, 2011

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. American Journal of Cardiology 99(12a): 4i-20i, 2007

Multifactorial lifestyle interventions in the primary and secondary prevention of cardiovascular disease and type 2 diabetes mellitus--a systematic review of randomized controlled trials. Annals of Behavioral Medicine 40(1): 49-64, 2011

Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention. Diabetes, Obesity and Metabolism 9(6): 792-798, 2007

Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus. Circulation 134(20): 1579-1594, 2016

Primary cardiovascular prevention with statins in type 2 diabetes mellitus. Medicina Clinica 144(9): 431-432, 2016